The Project Quality Management seeks to ensure that a project meets the customer's needs and involves all project activities during its life cycle. However, in technology transfer projects within the biopharmaceutical industry, the quality can not be measured only by the final product. Even if the product meets specifications, the absorption of knowledge and process parameters originated from scientific nature shall be documented and transferred to the technology absorber, so that it can internalize the activities in their routine production. With the creation of the International Conference on Harmonization -ICH 1990, it became possible to stablish a guideline to the study of factors affecting the safety, quality, effectiveness and multidisciplinarity of products in manufacturing processes as critical attributes. One of the regulatory practices that have been implemented is the Quality by Design (QbD) where, through a systematic approach to development, is emphasized the science and the risk management of quality, to ensure that the quality of a product is built in production processes from the beginning, rather than to be tested only at the end.
companies in technology transfer. With this, throughout the project it will be possible to see gaps that may influence negatively in the management of the product life cycle in each project phase.
CONCLUSION
The application of the QbD tool will allow the formation of a model with scientific principles in the quality management of a biopharmaceutical technology transfer project that will assist in the construction of the QTPP during the phases of the project. With this, the expectation is to provide a more efficient construction of quality, facilitating compliance with regulatory requirements, reducing thus risk of delays and rework during project execution.
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